Fluorescent Probes for α4β1 and Fn3 Integrin Binding
Corresponding Organization :
Other organizations : Boston Children's Hospital, Harvard University
Variable analysis
- FITC-labeled α4β1-specific probe, 4-((N′-2-methylphenyl)ureido)-phenylacetyl-L-leucyl-L-aspartyl-L-valyl-L-prolyl-L-alanyl-L-alanyl-L-lysine (FITC-LDVP)
- Unlabeled 4-((N′-2-methylphenyl)ureido)-phenylacetyl-L-leucyl-L-aspartyl-L-valyl-L-prolyl-L-alanyl-L-alanyl-L-lysine (LDVP)
- Human Fn3_9-10 S1417C mutant (mature residues G1326 to T1509)
- Human Fn3_9-10 S1417C mutant with synergy and RGD site (R1374A&P1376A&R1379A&S1417C&Δ1493-1496) mutations
- Binding of FITC-LDVP and LDVP to cells
- Fluorescence intensity of Alexa Fluor 488-labeled VCAM D1D2 and Fn3_9-10 S1417C mutant
- Human VCAM D1D2 (mature residues F1 to T202) expressed and purified from HEK 293S GnTI-/- cell line supernatants
- Fn3_9-10 S1417C mutant and its inactive version expressed in Escherichia coli and purified
- None specified
- Fn3_9-10 S1417C mutant with synergy and RGD site (R1374A&P1376A&R1379A&S1417C&Δ1493-1496) mutations
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!